Mendor Raises € 8.1 Million in a Series B Financing Round for Global Market Expansion

ESPOO, Finland, June 21, 2011 -

Mendor, a leading company in new diabetes technologies and
services, announces € 8.1 Million of Venture Capital financing to
facilitate its global market expansion. The series-B financing
round was led by the Finnish entrepreneur and investor Risto
Siilasmaa, joined by Life Sciences Partners (LSP), Finnish Industry
Investment Ltd., Finnish Mutual Pension Insurance Company
Ilmarinen, private Finnish investment group Biothom and the
Finnvera Venture Capital as a returning investor.

Founded in 2006 in Helsinki, Finland, Mendor designs, develops
and markets innovative diabetes care products and services.
Mendor’s first product, the all-in-one blood glucose meter
Discreet™, has received high praise from clinicians and
diabetologists all over the world. The meter contains all the
necessary components for daily blood glucose measurements: meter,
strips and lancing device in an integrated, all-in-one device the
size of a cell phone. Mendor Discreet™ is designed to simplify the
lives of people with diabetes who regularly need to test their
blood glucose levels.

The Mendor Balance™ application is a next generation web-based
software that supports the Discreet™ meter. The system can be
accessed anywhere once the data have been uploaded allowing
diabetes patients to take control of their condition by providing a
thorough analysis of their treatment. Pair measurements before and
after meals and sleep help to determine problem areas and means
that patients are able to manage their diabetes more
effectively.

Mendor brand video available at
www.youtube.com/watch?v=oHKnLzTgac0

Kristian Ranta, Mendor CEO and Co-Founder, commented, “We are
very happy to have such great investors joining the investment
round and helping us facilitate better self-care for diabetics all
over the world with Mendor’s innovative and ground breaking
products and services. Mendor is facing strong growth in the
upcoming years and a solid financial base will help us tremendously
in achieving our targets.”

Following the closing of the financing round, Anne Portwich, PhD
(Partner, LSP) will be joining the board of directors of
Mendor.

Recently Mendor was selected as a Red Herring Europe top 100
technology start-up.

More information from: www.mendor.com/Press.aspx

Press release / for immediate release 21st of June 2011

About Risto Siilasmaa

Risto Siilasmaa is the founder of F-Secure Corporation. He
served as the President and CEO of the company between 1988-2006.
He is the Chairman of the Board of Directors of F-Secure (since
2006), Elisa Corporation (since 2008) and Fruugo Inc. (since
2007).

About LSP

Life Sciences Parnters (LSP) is a leading independent European
investment firm, providing financing for private and public
life-science companies. Since the late 1980s, LSP’s management has
invested in a large number of highly innovative enterprises, many
of which have grown to become leaders of the global life-science
industry. For example, LSP was a founding investor in Movetis,
Crucell, DNage, Qiagen, Rhein Biotech and Pharming. With over EUR
500 million under management and offices in Amsterdam, Munich and
Boston, LSP is one of Europe’s largest and most experienced
specialist life-science investors. www.lspvc.com

About Ilmarinen

Ilmarinen Mutual Pension Insurance Company is responsible for
the statutory earnings-related pension security of employees and
self-employed persons and the investment assets that cover future
pensions. In 2010, Ilmarinen’s premiums written totalled EUR 3.4
billion and the company paid out EUR 3.3 billion in pensions. The
value of assets totalled EUR 28.1 billion at the end of 2010.
Ilmarinen is responsible for the pension cover of 850,000 people.
The company’s share of the market is about one third. More
information at: www.ilmarinen.fi

About Finnish Industry Investment Ltd.

Finnish Industry Investment Ltd is a government-owned investment
company. Its mission is to promote Finnish business, job creation
and economic growth through venture capital and private equity
investments. Finnish Industry Investment invests in funds and
directly in growth companies in all sectors. The investment focus
is on growth, internationalization, spin-offs, major industrial
investments, as well as sectoral and corporate restructurings.
Finnish Industry Investment collaborates closely with other
investors and always invests together with private co-investors.
With over €670m of capital under management, Finnish Industry
Investment’s portfolio consists of around 90 fund investments and
75 direct investments. www.industryinvestment.com

About Biothom

Biothom Oy, located in Helsinki, invests into companies
representing various areas of Life Sciences and has interests in
young, innovative companies in the United States, Finland and
Sweden. Biothom is a member of Thominvest Group, a privatively held
Finnish investment firm. www.thominvest.fi

For more information, visit: www.mendor.com

or please contact:

E-mail: href="mailto:kristian.ranta@mendor.com">kristian.ranta@mendor.com

Fax: +358-207-818-155

Mendor home page: www.mendor.com

Mendor on Twitter: twitter.com/mendor_com

Mendor on facebook: www.facebook.com/mendorfin

Kristian Ranta, CEO, Co-Founder, Mobile: +358-45-673-3313